News

Regeneron Pharmaceuticals sees strength in Dupixent, oncology gains, and major buybacks despite setbacks. Find out why REGN ...
Photo: Congratulations to the Regeneron Science Talent Search top three finalists (from left to right) Achyuta Rajaram, with second place winner Thomas Cong and third place awardee Michelle Wei.
LOS ANGELES, CA – Regeneron Pharmaceuticals, Inc. and the Society for Science on May 17 announced that Krish Pai, 17, of Del Mar, California, received the second Regeneron Young Scientist Award ...
Regeneron and Illumina have joined a major investment in health data specialist Truveta that will support the creation of a major new genome project.
Review Regeneron Pharmaceuticals Inc (REGN:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
Read about Regeneron Pharmaceuticals Inc (REGN:XNAS) stock and today's latest news and financial updates.
Hereditary retinal diseases are now the leading cause of blindness certification in the working age population (age 16–64 years) in England and Wales, of which retinitis pigmentosa (RP) is the most ...